Medications to treat alcohol use disorder can save lives and keep people out of hospital, but they remain out of reach for the vast majority of British Columbians living with the medical condition, according to a new study from researchers at the B.C. Centre on Substance Use.
First-line prescriptions naltrexone and acamprosate can reduce alcohol cravings and diminish the pleasurable impacts of drinking for people with alcohol use disorder (AUD), a chronic relapsing disease that Statistics Canada says killed more than 3,200 Canadians in 2019.
A peer-reviewed study published Monday in the journal, Addiction, found that people with AUD who accessed medications in B.C. were nearly half as likely to die or be
→ Continue reading at CBC News